A newly published case report in Frontiers in Neuroscience describes a remarkable and unexpected clinical response in an 80-year-old woman with advanced Alzheimer’s disease following a single high-dose psilocybin intervention.
The patient had lived with Alzheimer’s disease for approximately 10 years and experienced severe functional decline over the preceding five years. According to the report, she had become largely monosyllabic, demonstrated profound cognitive impairment, chronic urinary incontinence, impaired mobility, dysphagia, executive dysfunction and severe reduction in spontaneous communication and emotional engagement.
After receiving a single 5g oral dose of psilocybin-containing mushrooms (Enigma strain), the patient reportedly experienced rapid and sustained functional improvement across multiple domains.
During the acute phase, the patient entered a prolonged deep sleep-like state accompanied by profuse sweating and clinically suspected hyperthermia.
Then, approximately 19 hours later, something unexpected occurred.
The patient spontaneously awakened and began speaking for hours, engaging in autobiographical conversation and recalling memories that had not been expressed in years.
Over the following days, her family reported meaningful improvements in:
- Speech and communication.
- Memory and contextual recognition.
- Walking and mobility.
- Emotional connection and social engagement.
- Bladder control, after years of chronic urinary incontinence.
Hellbound and Down 